|Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.||
Fighting Malaria—the Right Way
Bate has been a vocal and persistent advocate for improving how aid organizations in the U.S. and abroad allocate funding for malaria treatment. In particular, Bate endorses the U.S. Agency for International Development's decision to shift its funding priorities from technical assistance to buying proven interventions against the disease.
The fight against malaria has scored a major victory. The [U.S. AID] has elected to use nearly half of its budget to buy proven interventions against the disease, which affects 500 million people and kills more than a million children around the world each year. USAID has promised $15 million expressly for insecticides, recognizing their unique effectiveness in reducing the burden of malaria. The agency has opted to streamline more funding to fewer countries in order to improve accountability and focus on results.
Bate challenges international donors to hold themselves accountable for improving outcomes, not simply spending.
|home spotlight commentary research events news about contact links archives|